RetINal Toxicity And HydroxyChloroquine Therapy (INTACT): protocol for a prospective population-based cohort study

Daftarian, N; Lima, A; Marozoff, S; Ojo, D; Levasseur, SD; Maberley, DAL; Hoens, A; Esdaile, J; Dawes, M; Avina-Zubieta, JA; Adante, B; Bhui, RD; Bhui, SB; Butler, M; Chui, L; Erasmus, M; Etminan, M; Godinho, D; Hay, E; Hollands, H; Hoonjan, M; Joe, A; Lukaris, A; Mammo, Z; Navajas, E; Pakzad-Vaezi, K; Sanmugasunderam, S; Shojania, K

Avina-Zubieta, JA (通讯作者)，Arthrit Res Canada, Vancouver, BC, Canada.;Avina-Zubieta, JA (通讯作者)，Univ British Columbia, Div Rheumatol, Fac Med, Vancouver, BC, Canada.

BMJ OPEN, 2022; 12 (2):

Abstract

Purpose Hydroxychloroquine (HCQ) is an important medication for patients with systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and other ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索